PofoliaShared via Pofolia

Science Translational Medicine· 2026Q1

Elevated translocator protein in skull bone marrow is linked to human chronic pain

Mehrbod Mohammadian, Nikos Efthimiou, Katherin A. Gabriel, Ludovica Brusaferri et al.

Short summary

Elevated levels of the translocator protein (TSPO), a marker of immune cell density, were found in the skull bone marrow (SBM) of individuals with chronic pain (n=125) compared to healthy controls (n=22).

AI-generated from the title and abstract; the full text is not read.

Key points

  • TSPO levels are elevated in the skull bone marrow of individuals with chronic pain (n=125) compared to healthy controls (n=22).
  • Elevations were observed in patients with chronic low back pain (n=88) and knee osteoarthritis (n=37).
  • Higher TSPO levels were generally more pronounced in knee osteoarthritis patients than in chronic low back pain patients.
  • TSPO elevations were associated with pain severity and comorbid symptoms, with partially segregated spatial patterns.
  • Preliminary immunohistochemistry in human SBM samples supports these findings.

AI-generated from the title and abstract; the full text is not read.

Abstract

The skull bone marrow (SBM) is emerging as a critical hub for neuroimmune signaling, yet its role in chronic pain is unknown. Using integrated positron emission tomography/magnetic resonance imaging, here, we show that the levels of 18-kilodalton translocator protein (TSPO), a putative marker of immune cell density, are elevated in the SBM of individuals with chronic pain [ n = 125; chronic low back pain (cLBP), n = 88; knee osteoarthritis (KOA), n = 37] compared with healthy controls ( n = 22). These elevations were widespread, generally more pronounced for KOA than cLBP, associated with pain and pain-comorbid symptoms in partially segregated spatial patterns, and supported by preliminary immunohistochemical evidence in human SBM samples from a donor with a history of chronic pain (compared with a healthy donor). Because TSPO is highly expressed in myeloid cells, these results link SBM immune dysregulation with chronic pain and its associated psychological and functional impairments. These findings provide a strong rationale for investigating this previously overlooked structure, which remains largely underexplored in the context of pain.

The authors' abstract, as published at the source. Science Translational Medicine, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Physiology

PhysiologyMedicine